ZOM Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ZOM shares is 101, representing 8.33% of the company's common stock.

CIBC PRIVATE WEALTH GROUP, LLC, in the last quarter, reduced its stake in ZOM by -0.2% restricting it's holding to 574.63 thousand shares of worth nearly $9.23M. SWISS NATIONAL BANK also lessened -2.83% of the ZOM shares from its portfolio, reducing its holding to 538.7 thousand shares of worth $8.64M. LEGAL & GENERAL GROUP PLC also shunned ZOM shares holding by -57.37% last quarter which brought its holding to 432.04 thousand shares worth $6.93B.

As per its latest 13F filing, QUBE RESEARCH & TECHNOLOGIES LTD increased its stake in ZOM by 100% in the last quarter. The institutional holder raised its holding to 682.16 thousand shares having worth more than $10.94M. MAKENA CAPITAL MANAGEMENT LLC also added 22.83% more shares of ZOM to its portfolio, raising its holding to 654.51 thousand shares of worth $10.49M. INVESCO LTD. also increased its ZOM shares holding by 18.95% which brought its holding to 567.1 thousand shares worth $9.09M.

The insider with the most stakes in ZOM is Solensky Gerald JR , President and CEO at the company. Additionally, ZOM stock is highly held by director POWERS JOHNNY D and Vice President of Sales Klass Russell Kevin among others.

Company executives, directors, and other insiders own 1.78% percent of Zomedica Corp.'s stock. Within the last six months, there have been 0 transaction(s) in which ZOM insiders have sold stock, totaling 0 shares. Insiders that have sold shares include COHEN ROBERT, POWERS JOHNNY D, and COTTER ANN MARIE.

There have been 4 transaction(s) during the past 6-months in which Zomedica Corp. insiders have bought stock, totalling 450000 shares

Around 5.55M Zomedica Corp. shares are held by insiders, which represents about 1.78% of ZOM stock.

ZOM President and CEO, Solensky Gerald JR holds the largest portfolio of the company's shares. ZOM shares owned by Solensky total nearly 37.95 million.

QUBE RESEARCH & TECHNOLOGIES LTD is the largest institutional owner in ZOM which holds 682.16 thousand shares worth $10.94M or 0.07% of the total ZOM shares outstanding followed by MAKENA CAPITAL MANAGEMENT LLC with ownership of 654.51 thousand shares representing 0.07% of the ZOM ownership. CIBC PRIVATE WEALTH GROUP, LLC is the third largest stakeholder with 574.63 thousand shares or 0.06% of the ownership worth more than $9.23M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ZOM is concerned, it is a stock which is not optionable.

Number of ZOM shares short is 44.59M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 979.95M shares of ZOM are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ZOM has 961.65M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ZOM is 6.22.